Online citations, reference lists, and bibliographies.

Cerebral Amyloid Angiopathy: Diagnosis And Potential Therapies

Stewart A Weber, R K Patel, Helmi L. Lutsep
Published 2018 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
ABSTRACT Introduction: Cerebral amyloid angiopathy (CAA) is characterized by the pathologic deposition of amyloid-beta within cortical and leptomeningeal arteries, arterioles, capillaries and, in rare cases, the venules of the brain. It is often associated with the development of lobar intracerebral hemorrhages (ICHs) but may cause other neurologic symptoms or be asymptomatic. Magnetic resonance imaging characteristics, such as lobar microbleeds, support a diagnosis of CAA and assist with hemorrhage risk assessments. Immunosuppressants are used to treat rarer inflammatory forms of CAA. For the more common forms of CAA, the use of antihypertensive medications can prevent ICH recurrence while the use of antithrombotics may increase hemorrhage risk. Anti-amyloid approaches to treatment have not yet been investigated in phase 3 trials. Areas covered: A literature search was conducted using MEDLINE on the topics of imaging, biomarkers, ICH prevention and treatment trials in CAA, focusing on its current diagnosis and management and opportunities for future therapeutic approaches. Expert commentary: There is likely a significant unrecognized burden of CAA in the elderly population. Continued research efforts to discover biomarkers that allow the early diagnosis of CAA will enhance the opportunity to develop treatment interventions.
This paper references
10.1212/01.wnl.0000435298.80023.7a
Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy
Andreas Charidimou (2013)
10.1016/S0009-9260(99)90825-5
Intracerebral haemorrhage and cerebral amyloid angiopathy: CT features with pathological correlation.
John H. Miller (1999)
10.1016/j.neurobiolaging.2009.11.012
Differential recognition of vascular and parenchymal beta amyloid deposition
Kim S. Rutgers (2011)
10.1002/ana.20596
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy.
Jonathan Rosand (2005)
10.1161/STROKEAHA.112.655894
Statin Therapy and the Risk of Intracerebral Hemorrhage: A Meta-Analysis of 31 Randomized Controlled Trials
James S. McKinney (2012)
10.1212/WNL.0000000000003183
Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA
Duncan Wilson (2016)
10.1097/WCO.0000000000000510
The growing clinical spectrum of cerebral amyloid angiopathy
Marieke J. H. Wermer (2018)
10.1016/j.humpath.2017.01.008
Amyloid-β-related angiitis: a report of 2 cases with unusual presentations.
Denise W Ng (2017)
10.1161/STROKEAHA.113.002267
Susceptibility-Weighted Imaging is More Reliable Than T2*-Weighted Gradient-Recalled Echo MRI for Detecting Microbleeds
Ah-Ling Cheng (2013)
10.1016/j.compmedimag.2015.10.001
Computer-aided detection of cerebral microbleeds in susceptibility-weighted imaging
Amir H. Fazlollahi (2015)
This meta-analysis in patients with recent ischemic stroke and atrial fibrillation on long-term oral anticoagulant treatment revealed an increase in intracerebral hemorrhage risk with microbleeds
10.1212/01.wnl.0000260066.98681.2e
Course of cerebral amyloid angiopathy–related inflammation
Catherine Kinnecom (2007)
10.3174/ajnr.A2450
Cerebral Microbleeds on MR Imaging: Comparison between 1.5 and 7T
Mandy M. A. Conijn (2011)
10.1161/STROKEAHA.117.016990
Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria.
Steven M. Greenberg (2018)
10.1159/000097030
Steroid-Responsive Recurrent Encephalopathy in a Patient with Cerebral Amyloid Angiopathy
John C. Mchugh (2006)
10.1056/NEJMoa061894
High-dose atorvastatin after stroke or transient ischemic attack.
Pierre Amarenco (2006)
This article illustrates that cortical superficial siderosis, especially with increasing multifocality, is associated with recurrent intracerebral hemorrhage risk in CAA
10.1212/WNL.0000000000000022
Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage
Solveig Horstmann (2014)
10.1136/jnnp-2012-303898
Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis
Kristiina Rannikmäe (2013)
10.1016/S1474-4422(18)30006-1
The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study
Mark Alexander Rodrigues (2018)
Brain reactive b-amyloid antibodies in primary CNS angiitis with cerebral amyloid angiopathy
DM Hermann (2011)
10.1016/S1474-4422(16)00070-3
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson (2016)
10.3174/ajnr.A1355
MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength
R. N. Kaveer Nandigam (2009)
10.1212/WNL.0b013e3182a9f545
A&bgr;-related angiitis: Comparison with CAA without inflammation and primary CNS vasculitis
Carlo Salvarani (2013)
Core CSF biomarker profile in cerebral amyloid angiopathy. Neurology
A Charidimou (2018)
10.1212/WNL.0000000000004668
Evolution of DWI lesions in cerebral amyloid angiopathy
Susanne J. van Veluw (2017)
10.1136/jnnp.2009.204180
Cerebral amyloid angiopathy related inflammation: three case reports and a review
Kong Khi Chung (2010)
10.1016/j.jns.2017.04.042
Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema
Andreas Charidimou (2017)
10.1212/WNL.0b013e3181eee40f
Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy
A. Biffi (2010)
10.1001/jama.2015.10082
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.
Alessandro Biffi (2015)
10.1046/j.1440-1789.2003.00506.x
Subcortical hematoma caused by cerebral amyloid angiopathy: does the first evidence of hemorrhage occur in the subarachnoid space?
Shigeki Takeda (2003)
10.1097/MD.0000000000003613
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy–Related Inflammation
Carlo Salvarani (2016)
10.1148/rg.265055090
Cerebral amyloid angiopathy: CT and MR imaging findings.
Christine P. Chao (2006)
10.1212/WNL.0000000000003486
&bgr;-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy
Ellis S. van Etten (2017)
Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment
S M Greenberg (1998)
10.1212/WNL.0b013e3182194be9
Statin use and outcome after intracerebral hemorrhage
A. Biffi (2011)
10.1016/j.jvs.2006.10.008
High-dose Atorvastatin After Stroke or Transient Ischemic Attack
Pierre Amarenco (2006)
10.1212/WNL.0000000000004665
Cortical superficial siderosis multifocality in cerebral amyloid angiopathy
Andreas Charidimou (2017)
10.1212/WNL.0000000000004704
Brain microbleeds, anticoagulation, and hemorrhage risk
Andreas Charidimou (2017)
10.1136/jnnp-2015-310690
Mapping the landscape of cerebral amyloid angiopathy research: an informetric analysis perspective
Andreas Charidimou (2015)
10.1002/ana.21694
Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy.
Marcel M. Verbeek (2009)
10.1212/WNL.0000000000005030
Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy
Andreas Charidimou (2018)
10.1212/WNL.0b013e318227b250
Brain-reactive β-amyloid antibodies in primary cns angiitis with cerebral amyloid angiopathy
Dirk M. Hermann (2011)
10.1161/STROKEAHA.109.554378
Descriptive Analysis of the Boston Criteria Applied to a Dutch-Type Cerebral Amyloid Angiopathy Population
Sanneke van Rooden (2009)
AB-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology
C Salvarani (2013)
Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack
P Amarenco (2006)
Intracerebral hemorrhage caused by cerebral amyloid angiopathy: radiographic-pathologic correlation.
William A. Wagle (1984)
10.1177/1941874415569071
A 61-Year-Old Woman With Headaches and Aphasia
Adam Reynolds (2015)
This article provides an overview of the radiographic principles that dictate the usefulness of different imaging modalities in detecting cerebral microbleeds
10.1161/STROKEAHA.117.018467
Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds Be Anticoagulated?
Ashkan Shoamanesh (2017)
10.1136/jnnp-2011-301308
Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum
Andreas Charidimou (2011)
Leukoencephalopathy in cerebral amyloid angiopathy: MR imaging in four cases.
D J Loes (1990)
10.1046/j.1440-1789.2000.00268.x
Cerebral amyloid angiopathy: an overview.
Masahito Yamada (2000)
10.1136/jnnp-2013-306485
APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis
Kristiina Rannikmäe (2013)
Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy.
Neil J Scolding (2005)
10.1097/00005072-199907000-00005
The apolipoprotein E ∈2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage
Mark O McCarron (1999)
10.1016/0090-3019(96)00158-9
Amyloid angiopathy-related cerebellar hemorrhage.
Emmanuel Cuny (1996)
10.1021/acs.molpharmaceut.5b00209
99mTc(CO)3-Labeled Benzothiazole Derivatives Preferentially Bind Cerebrovascular Amyloid: Potential Use as Imaging Agents for Cerebral Amyloid Angiopathy.
Jianhua Jia (2015)
10.1161/STROKEAHA.109.548974
Microbleeds Versus Macrobleeds: Evidence for Distinct Entities
Steven M. Greenberg (2009)
10.1016/j.jmb.2011.11.047
Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease.
Sherry L La Porte (2012)
10.1111/j.1749-6632.2000.tb06366.x
Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.
Mark O McCarron (2000)
10.1002/ana.410180110
Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy.
Françoise Gray (1985)
10.1212/WNL.0000000000003197
Florbetapir-PET to diagnose cerebral amyloid angiopathy
M. E. Gurol (2016)
10.1016/j.nicl.2016.07.002
Automated detection of cerebral microbleeds in patients with Traumatic Brain Injury
T.L.A. van den Heuvel (2016)
10.1212/WNL.0000000000000732
Posterior white matter disease distribution as a predictor of amyloid angiopathy
Sekh Thanprasertsuk (2014)
10.1097/RMR.0000000000000080
7-T MRI in Cerebrovascular Diseases: Challenges to Overcome and Initial Results
Anita A. Harteveld (2016)
10.1001/archneurol.2009.42
Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study.
Meike W. Vernooij (2009)
Core CSF biomarker profile in cerebral amyloid angiopathy: A meta-analysis
Tian Li (2018)
10.1002/ana.21164
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.
Keith A. Johnson (2007)
10.1002/ana.23845
Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.
Jae-Hyun Park (2013)
10.1212/WNL.0b013e31820e773c
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: A case report
Jacopo C. DiFrancesco (2011)
10.1161/01.STR.18.2.311
Cerebral amyloid angiopathy. A critical review.
H V Vinters (1987)
10.1177/0271678X15620434
Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces
Susanne J. van Veluw (2016)
10.1161/STROKEAHA.116.014418
Early Magnetic Resonance Imaging and Cognitive Markers of Hereditary Cerebral Amyloid Angiopathy
Sanneke van Rooden (2016)
10.1161/STROKEAHA.109.563932
Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
Hisatomi Arima (2010)
Randomised trial of a perindoprilbased blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
Progress Collaborative Group (2001)
Association of apolipoprotein E ε2 vasculopathy in cerebral amyloid angiopathy
SM Greenberg (1998)
This study consists of two retrospective analyses establishing microbleeds and macrobleeds as distinct entities with separate pathophysiologies
10.1002/ana.10810
Clinical manifestations of cerebral amyloid angiopathy-related inflammation.
Jessica A Eng (2004)
10.1136/jnnp-2012-304434
Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study
Andreas Charidimou (2013)
10.1093/brain/awx047
Emerging concepts in sporadic cerebral amyloid angiopathy.
Andreas Charidimou (2017)
10.1002/jmri.22513
7 tesla MRI of microbleeds and white matter lesions as seen in vascular dementia.
Jens Matthias Theysohn (2011)
10.1016/S1474-4422(14)70003-1
Outcome markers for clinical trials in cerebral amyloid angiopathy
Steven M. Greenberg (2014)
Statin Use Following Intracerebral Hemorrhage
M. Brandon Westover (2011)
10.1212/WNL.0000000000004539
Amyloid-PET in sporadic cerebral amyloid angiopathy
Andreas Charidimou (2017)
10.1016/S1474-4422(09)70013-4
Cerebral microbleeds: a guide to detection and interpretation
Steven M. Greenberg (2009)
10.1016/j.jstrokecerebrovasdis.2015.02.018
Non-vitamin k antagonist oral anticoagulants do not increase cerebral microbleeds.
Tsukasa Saito (2015)
10.1212/01.wnl.0000339060.11702.dd
Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage
Sang Hyun Lee (2009)
10.1093/jnen/61.3.282
Two Types of Sporadic Cerebral Amyloid Angiopathy
Dietmar Rudolf Thal (2002)
10.1093/brain/awh379
Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy
Neil J Scolding (2005)
10.1111/j.1750-3639.2009.00322.x
Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy.
Virawudh Soontornniyomkij (2010)
intracerebral hemorrhage risk in CAA
SL La Porte (2018)
Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology
SM Greenberg (1998)
10.1093/brain/awr172
Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study.
Simone M. Gregoire (2011)
10.7488/DS/2262
The Edinburgh diagnostic criteria for lobar intracerebral haemorrhage associated with moderate/severe cerebral amyloid angiopathy
Rustam Al-Shahi Salman (2017)
10.1136/jnnp-2016-314697
The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice
Gargi Banerjee (2017)
10.1111/j.1600-0404.1994.tb02648.x
Co-localization of beta/A4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis.
Joost Haan (1994)
10.1097/RLI.0000000000000256
Comparison of Routine Brain Imaging at 3 T and 7 T
Elisabeth Springer (2016)
10.1016/j.neurobiolaging.2015.08.008
APOE and cerebral amyloid angiopathy in community-dwelling older persons
Lei Yu (2015)
10.1161/01.STR.0000078311.18928.16
Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis
Mark H. Eckman (2003)
This article provides clinical features to help to differentiate between β-amyloid-related angiitis and primary central nervous system vasculitis
CO)3-labeled benzothiazole derivatives preferentially bind cerebrovascular amyloid: potential use as imaging agents for cerebral amyloid angiopathy
J Jia (2015)
10.1016/j.bbadis.2015.08.024
Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy☆
Abby Keable (2016)
10.1016/S1474-4422(12)70015-7
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling (2012)
10.1007/s00401-009-0615-z
Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study
Matthew Schrag (2009)
10.1212/CPJ.0000000000000354
Focal cerebral β-amyloid angiopathy: A distinct clinicopathologic presentation.
Elissaios Karageorgiou (2017)
10.1001/archneurol.2010.356
Statin use following intracerebral hemorrhage: a decision analysis.
M. Brandon Westover (2011)
10.1161/STROKEAHA.115.009208
Estimating Total Cerebral Microinfarct Burden From Diffusion-Weighted Imaging
Eitan Auriel (2015)
10.1161/STROKEAHA.114.005151
Incidence of Symptomatic Hemorrhage in Patients With Lobar Microbleeds
Ellis S. van Etten (2014)
10.1038/jcbfm.2014.43
Diagnostic Utility of Amyloid PET in Cerebral Amyloid Angiopathy-Related Symptomatic Intracerebral Hemorrhage
Jean-Claude Baron (2014)
10.1002/ana.21528
Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B.
Steven M. Greenberg (2008)
10.1212/WNL.56.4.537
Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria
Katherine A Knudsen (2001)
Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
Stephen MacMahon (2001)
β-amyloid in CSF: biomarker for preclinical cerebral amyloid angiopathy. Neurology. 2017;88:169–176
ES Van Etten (2017)
10.1212/WNL.0000000000004228
Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages
Nicolas Raposo (2017)
10.1212/WNL.50.4.961
Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy
Steven M. Greenberg (1998)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar